Apparel - Retail
Compare Stocks
5 / 10Stock Comparison
LVLU vs CURV vs XPOF vs CPRI vs VERA
Revenue, margins, valuation, and 5-year total return — side by side.
Apparel - Retail
Leisure
Luxury Goods
Biotechnology
LVLU vs CURV vs XPOF vs CPRI vs VERA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Apparel - Retail | Apparel - Retail | Leisure | Luxury Goods | Biotechnology |
| Market Cap | $6.28B | $160M | $244M | $2.23B | $2.57B |
| Revenue (TTM) | $285M | $1.00B | $299M | $3.71B | $0.00 |
| Net Income (TTM) | $-45M | $-7M | $-34M | $-504M | $-369M |
| Gross Margin | 41.8% | 34.8% | 83.2% | 61.4% | — |
| Operating Margin | -16.7% | 2.1% | 7.8% | -1.8% | — |
| Forward P/E | — | — | 10.9x | 13.4x | — |
| Total Debt | $39M | $149M | $525M | $3.10B | $77M |
| Cash & Equiv. | $4M | $20M | $46M | $166M | $355M |
LVLU vs CURV vs XPOF vs CPRI vs VERA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 21 | May 26 | Return |
|---|---|---|---|
| Lulu's Fashion Loun… (LVLU) | 100 | 5.2 | -94.8% |
| Torrid Holdings Inc. (CURV) | 100 | 9.4 | -90.6% |
| Xponential Fitness,… (XPOF) | 100 | 33.6 | -66.4% |
| Capri Holdings Limi… (CPRI) | 100 | 31.6 | -68.4% |
| Vera Therapeutics, … (VERA) | 100 | 100.2 | +0.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LVLU vs CURV vs XPOF vs CPRI vs VERA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LVLU is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 1 yrs, beta 0.41
- Beta 0.41 vs CPRI's 2.03, lower leverage
- +60.7% vs CURV's -70.9%
CURV ranks third and is worth considering specifically for efficiency.
- -1.7% ROA vs VERA's -60.2%, ROIC 22.5% vs -54.6%
XPOF carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth -1.7%, EPS growth 35.2%, 3Y rev CAGR 9.0%
- -1.7% revenue growth vs VERA's -111.5%
- Better valuation composite
- 2.5% yield; the other 4 pay no meaningful dividend
Among these 5 stocks, CPRI doesn't own a clear edge in any measured category.
VERA is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 212.0% 10Y total return vs XPOF's -46.6%
- Lower volatility, beta 1.35, Low D/E 12.8%, current ratio 13.64x
- Beta 1.35, current ratio 13.64x
- 2.3% margin vs LVLU's -15.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -1.7% revenue growth vs VERA's -111.5% | |
| Value | Better valuation composite | |
| Quality / Margins | 2.3% margin vs LVLU's -15.8% | |
| Stability / Safety | Beta 0.41 vs CPRI's 2.03, lower leverage | |
| Dividends | 2.5% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +60.7% vs CURV's -70.9% | |
| Efficiency (ROA) | -1.7% ROA vs VERA's -60.2%, ROIC 22.5% vs -54.6% |
LVLU vs CURV vs XPOF vs CPRI vs VERA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
LVLU vs CURV vs XPOF vs CPRI vs VERA — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
XPOF leads in 1 of 6 categories
VERA leads 1 • LVLU leads 0 • CURV leads 0 • CPRI leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — XPOF and CPRI each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CPRI and VERA operate at a comparable scale, with $3.7B and $0 in trailing revenue. CURV is the more profitable business, keeping -0.7% of every revenue dollar as net income compared to LVLU's -15.8%. On growth, LVLU holds the edge at -8.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $285M | $1.0B | $299M | $3.7B | $0 |
| EBITDAEarnings before interest/tax | -$42M | $75M | $35M | $72M | -$382M |
| Net IncomeAfter-tax profit | -$45M | -$7M | -$34M | -$504M | -$369M |
| Free Cash FlowCash after capex | $1M | -$22M | -$3M | $491M | -$294M |
| Gross MarginGross profit ÷ Revenue | +41.8% | +34.8% | +83.2% | +61.4% | — |
| Operating MarginEBIT ÷ Revenue | -16.7% | +2.1% | +7.8% | -1.8% | — |
| Net MarginNet income ÷ Revenue | -15.8% | -0.7% | -11.3% | -13.6% | — |
| FCF MarginFCF ÷ Revenue | +0.5% | -2.2% | -1.1% | +13.2% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | -8.6% | -14.3% | -21.0% | -18.7% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +25.2% | -185.7% | +79.1% | +120.8% | -108.6% |
Valuation Metrics
XPOF leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, XPOF's 7.9x EV/EBITDA is more attractive than CURV's 13.5x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $6.3B | $160M | $244M | $2.2B | $2.6B |
| Enterprise ValueMkt cap + debt − cash | $6.3B | $290M | $723M | $5.2B | $2.3B |
| Trailing P/EPrice ÷ TTM EPS | -113.24x | -21.86x | -4.45x | -1.87x | -7.70x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 10.90x | 13.36x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 13.53x | 7.89x | — | — |
| Price / SalesMarket cap ÷ Revenue | 19.87x | 0.16x | 0.78x | 0.50x | — |
| Price / BookPrice ÷ Book value/share | 469.50x | — | — | 5.94x | 3.81x |
| Price / FCFMarket cap ÷ FCF | — | — | 9.86x | 14.55x | — |
Profitability & Efficiency
Evenly matched — XPOF and VERA each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
VERA delivers a -74.9% return on equity — every $100 of shareholder capital generates $-75 in annual profit, vs $-18 for LVLU. VERA carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to CPRI's 8.34x. On the Piotroski fundamental quality scale (0–9), XPOF scores 5/9 vs VERA's 1/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -17.9% | — | — | -4.7% | -74.9% |
| ROA (TTM)Return on assets | -43.6% | -1.7% | -9.5% | -15.1% | -60.2% |
| ROICReturn on invested capital | -53.9% | +22.5% | +75.0% | -13.6% | -54.6% |
| ROCEReturn on capital employed | -86.3% | +11.4% | +30.3% | -17.0% | -48.1% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 5 | 4 | 1 |
| Debt / EquityFinancial leverage | 2.94x | — | — | 8.34x | 0.13x |
| Net DebtTotal debt minus cash | $35M | $129M | $479M | $2.9B | -$277M |
| Cash & Equiv.Liquid assets | $4M | $20M | $46M | $166M | $355M |
| Total DebtShort + long-term debt | $39M | $149M | $525M | $3.1B | $77M |
| Interest CoverageEBIT ÷ Interest expense | -20.21x | 0.84x | -0.24x | — | -31.22x |
Total Returns (Dividends Reinvested)
VERA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in VERA five years ago would be worth $31,200 today (with dividends reinvested), compared to $515 for LVLU. Over the past 12 months, LVLU leads with a +60.7% total return vs CURV's -70.9%. The 3-year compound annual growth rate (CAGR) favors VERA at 68.1% vs XPOF's -39.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +88.6% | +44.3% | -18.5% | -23.4% | -26.2% |
| 1-Year ReturnPast 12 months | +60.7% | -70.9% | -22.6% | +18.4% | +58.6% |
| 3-Year ReturnCumulative with dividends | -74.5% | -60.1% | -77.4% | -50.5% | +374.6% |
| 5-Year ReturnCumulative with dividends | -94.8% | -93.7% | -46.6% | -68.6% | +212.0% |
| 10-Year ReturnCumulative with dividends | -94.8% | -93.7% | -46.6% | -63.1% | +212.0% |
| CAGR (3Y)Annualised 3-year return | -36.6% | -26.4% | -39.1% | -20.9% | +68.1% |
Risk & Volatility
Evenly matched — LVLU and CPRI each lead in 1 of 2 comparable metrics.
Risk & Volatility
LVLU is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than CPRI's 2.03 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CPRI currently trades 66.1% from its 52-week high vs CURV's 25.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.41x | 0.46x | 1.94x | 2.03x | 1.35x |
| 52-Week HighHighest price in past year | $32.32 | $6.08 | $11.14 | $28.27 | $56.05 |
| 52-Week LowLowest price in past year | $2.98 | $0.94 | $3.83 | $15.37 | $18.76 |
| % of 52W HighCurrent price vs 52-week peak | +31.2% | +25.2% | +58.7% | +66.1% | +64.0% |
| RSI (14)Momentum oscillator 0–100 | 46.8 | 35.2 | 48.4 | 47.3 | 41.1 |
| Avg Volume (50D)Average daily shares traded | 25K | 852K | 626K | 2.5M | 1.2M |
Analyst Outlook
Evenly matched — LVLU and CURV each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: LVLU as "Hold", CURV as "Hold", XPOF as "Buy", CPRI as "Hold", VERA as "Buy". Consensus price targets imply 116.3% upside for VERA (target: $78) vs -80.2% for LVLU (target: $2). XPOF is the only dividend payer here at 2.50% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $2.00 | $1.51 | $8.00 | $25.33 | $77.60 |
| # AnalystsCovering analysts | 9 | 10 | 14 | 53 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — | +2.5% | — | — |
| Dividend StreakConsecutive years of raises | 1 | 1 | 0 | — | — |
| Dividend / ShareAnnual DPS | — | — | $0.16 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | 0.0% | 0.0% | +0.2% | 0.0% |
XPOF leads in 1 of 6 categories (Valuation Metrics). VERA leads in 1 (Total Returns). 4 tied.
LVLU vs CURV vs XPOF vs CPRI vs VERA: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is LVLU or CURV or XPOF or CPRI or VERA a better buy right now?
For growth investors, Xponential Fitness, Inc.
(XPOF) is the stronger pick with -1. 7% revenue growth year-over-year, versus -11. 1% for Lulu's Fashion Lounge Holdings, Inc. (LVLU). Analysts rate Xponential Fitness, Inc. (XPOF) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — LVLU or CURV or XPOF or CPRI or VERA?
Over the past 5 years, Vera Therapeutics, Inc.
(VERA) delivered a total return of +212. 0%, compared to -94. 8% for Lulu's Fashion Lounge Holdings, Inc. (LVLU). Over 10 years, the gap is even starker: VERA returned +212. 0% versus LVLU's -94. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — LVLU or CURV or XPOF or CPRI or VERA?
By beta (market sensitivity over 5 years), Lulu's Fashion Lounge Holdings, Inc.
(LVLU) is the lower-risk stock at 0. 41β versus Capri Holdings Limited's 2. 03β — meaning CPRI is approximately 393% more volatile than LVLU relative to the S&P 500. On balance sheet safety, Vera Therapeutics, Inc. (VERA) carries a lower debt/equity ratio of 13% versus 8% for Capri Holdings Limited — giving it more financial flexibility in a downturn.
04Which is growing faster — LVLU or CURV or XPOF or CPRI or VERA?
By revenue growth (latest reported year), Xponential Fitness, Inc.
(XPOF) is pulling ahead at -1. 7% versus -11. 1% for Lulu's Fashion Lounge Holdings, Inc. (LVLU). On earnings-per-share growth, the picture is similar: Xponential Fitness, Inc. grew EPS 35. 2% year-over-year, compared to -176. 7% for Lulu's Fashion Lounge Holdings, Inc.. Over a 3-year CAGR, XPOF leads at 9. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — LVLU or CURV or XPOF or CPRI or VERA?
Vera Therapeutics, Inc.
(VERA) is the more profitable company, earning 0. 0% net margin versus -26. 6% for Capri Holdings Limited — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: XPOF leads at 25. 3% versus -16. 9% for CPRI. At the gross margin level — before operating expenses — XPOF leads at 75. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is LVLU or CURV or XPOF or CPRI or VERA more undervalued right now?
On forward earnings alone, Xponential Fitness, Inc.
(XPOF) trades at 10. 9x forward P/E versus 13. 4x for Capri Holdings Limited — 2. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VERA: 116. 3% to $77. 60.
07Which pays a better dividend — LVLU or CURV or XPOF or CPRI or VERA?
In this comparison, XPOF (2.
5% yield) pays a dividend. LVLU, CURV, CPRI, VERA do not pay a meaningful dividend and should not be held primarily for income.
08Is LVLU or CURV or XPOF or CPRI or VERA better for a retirement portfolio?
For long-horizon retirement investors, Lulu's Fashion Lounge Holdings, Inc.
(LVLU) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 41)). Capri Holdings Limited (CPRI) carries a higher beta of 2. 03 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LVLU: -94. 8%, CPRI: -63. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between LVLU and CURV and XPOF and CPRI and VERA?
These companies operate in different sectors (LVLU (Consumer Cyclical) and CURV (Consumer Cyclical) and XPOF (Consumer Cyclical) and CPRI (Consumer Cyclical) and VERA (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
XPOF pays a dividend while LVLU, CURV, CPRI, VERA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.